机译:Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection
The Texas Liver InstituteSan Antonio,TX,USA;
Department of Infectious Diseases and HepatologyMedical University of BialystokBialystok,Poland;
AbbVie, Inc.North Chicago,IL,USADepartment of MedicineMassachusetts General HospitalBoston,MA,USADepartment of Internal MedicineYonsei University College of MedicineSeoul,South KoreaNorthwest Louisiana NephrologyShreveport,LA,USADepartment of Renal MedicineKarolinska University HospitalStockholm,SwedenDepartment of Internal MedicineUniversity Medical Center of the Johannes Gutenberg‐UniversityInternal Medicine and Hepatology UnitUniversity of SalernoSalerno,ItalyCarolinas Medical CenterCharlotte,NC,USA;
chronic kidney disease; cirrhosis; direct‐acting antiviral; hepatitis C virus; pangenotypic;